Medicines and Healthcare Products Regulatory Agency

Grantee Website London, United Kingdom
Purpose
to develop first International Standard for Influenza HA stalk based antibody to accelerating Universal flu vaccine development
Division
Global Health
Date
MARCH 2018
Region Served
GLOBAL,
EUROPE,
NORTH AMERICA
Committed Amount
$375,710
Grant Topic
Pneumonia
Duration (Months)
22
Grantee Location
London, United Kingdom

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.